✦ LIBER ✦

Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema

✍ Scribed by Murat Bas; Thomas K. Hoffmann; Bernd Tiemann; Vu Thao-Vi Dao; Christos Bantis; Vera Balz; Hans-Jürgen Schultz-Coulon; Thomas Stark; Patrick Schuler; Jens Greve; Katrin Ivens; Henning Bier; Georg Kojda

Book ID: 108642433
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 684 KB
Volume: 69
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2009.03567.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensin converting enzyme inhibitor

Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors

✍ T. Hoover; M. Lippmann; E. Grouzmann; F. Marceau; P. Herscu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Increased frequency and severity of angi

Increased frequency and severity of angio-oedema related to long-term therapy with angiotensin-converting enzyme inhibitor in two patients

✍ M.M.A. KOZEL; J.R. MEKKES; J.D. BOS 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Potential protective role of angiotensin

Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats

✍ M. A. Abd El-Aziz; A. I. Othman; M. Amer; M. A. El-Missiry 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract Captopril and enalapril—angiotensin‐converting enzyme (ACE) inhibitors—were evaluated for their antioxidative protective action against adriamycin‐induced cardiac and hepatic toxicity. Rats were treated with either captopril (10 mg kg^−1^) or enalapril (2 mg kg^−1^) intragastrically (i.